Marshall Wace’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-41,285
| Closed | -$3.3M | – | 3502 |
|
|
2021
Q1 | $3.3M | Buy |
41,285
+34,745
| +531% | +$2.71M | 0.02% | 1058 |
|
|
2020
Q4 | $515K | Sell |
6,540
-37,038
| -85% | -$2.17M | ﹤0.01% | 1447 |
|
|
2020
Q3 | $1.92M | Buy |
+43,578
| New | +$2.15M | 0.01% | 820 |
|
|
2020
Q2 | – | Sell |
-6,321
| Closed | -$227K | – | 2100 |
|
|
2020
Q1 | $227K | Buy |
+6,321
| New | +$359K | ﹤0.01% | 1160 |
|
|
2019
Q3 | – | Sell |
-3,418
| Closed | -$276K | – | 2012 |
|
|
2019
Q2 | $276K | Buy |
3,418
+2,057
| +151% | +$145K | ﹤0.01% | 1194 |
|
|
2019
Q1 | $91K | Sell |
1,361
-101,904
| -99% | -$7.72M | ﹤0.01% | 1452 |
|
|
2018
Q4 | $7.69M | Sell |
103,265
-22,402
| -18% | -$1.85M | 0.08% | 317 |
|
|
2018
Q3 | $11.6M | Buy |
+125,667
| New | +$12M | 0.1% | 276 |
|
|
2016
Q4 | – | Sell |
-5,605
| Closed | -$437K | – | 1177 |
|
|
2016
Q3 | $437K | Sell |
5,605
-37,735
| -87% | -$2.74M | ﹤0.01% | 815 |
|
|
2016
Q2 | $2.98M | Buy |
+43,340
| New | +$2.99M | 0.03% | 505 |
|
|
2015
Q3 | – | Sell |
-5,134
| Closed | -$276K | – | 1114 |
|
|
2015
Q2 | $276K | Buy |
+5,134
| New | +$250K | ﹤0.01% | 781 |
|
Marshall Wace's CMD Position: Q2 2021 in Review
Marshall Wace sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 41,285 shares — an estimated $3.3M sold.
Marshall Wace first reported a position in CMD in Q2 2015 and held it in 11 quarters. The position peaked at $11.6M in Q3 2018. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- Marshall Wace reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Marshall Wace sold 41,285 Cantel Medical Corporation shares in Q2 2021, an estimated $3.3M.
- Marshall Wace first reported a position in Cantel Medical Corporation in Q2 2015 and held it in 11 quarters.
- Marshall Wace's Cantel Medical Corporation position peaked at $11.6M in Q3 2018.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on Marshall Wace's 13F filing for Q2 2021, filed 13 Aug 2021.